VoxelLTS:0QDB 97 Median PS Value is zł84.44 as of Jul. 01, 2026, which is 100% below its 10-year median of 1.28. GuruFocus rates LTS:0QDB with a GF Score™ of 97/100 and a GF Value™ of zł128.03. The stock has 2 warning signs investors should review. Among 87 Medical Diagnostics & Research companies, Voxel ranks worse than 79.31% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Voxel's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was zł55.523. Voxel's 10-Year median PS Ratio is 1.5208. Therefore, the Median PS Value for today is zł84.44.
As of today (2026-07-01), Voxel's share price is zł109.00. Voxel's Median PS Value is zł84.44. Therefore, Voxel's Price to Median PS Value for today is 1.29.
The historical rank and industry rank for Voxel's Median PS Value or its related term are showing as below:
LTS:0QDB'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.57 Med: 1.28 Max: 1.94
Current: 1.29
During the past 13 years, the highest Price to Median PS Value of Voxel was 1.94. The lowest was 0.57. And the median was 1.28.
LTS:0QDB's Price-to-Median-PS-Value is ranked worse than 79.31% of 87
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.88
vs LTS:0QDB: 1.29
Voxel (LTS:0QDB) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Voxel's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
109.00
/
84.44
=
1.29
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Voxel Median PS Value Related Terms
Voxel Median PS Value Historical Data
* Premium members only.
The historical data trend for Voxel's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0QDB vs TMO, DHR, IDXX: Median PS Value Comparison
For the Diagnostics & Research subindustry, Voxel's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Voxel Price-to-Median-PS-Value vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Voxel's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Voxel's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 1.5208.
Voxel's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł55.523.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Voxel (LTS:0QDB) has a Median PS Value of zł84.44 as of Jul. 01, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Voxel and its competitors. This is 6497% above median its historical median of 1.28. Over the past decade, Voxel's Median PS Value has ranged from 0.57 to 1.94. According to the industry distribution chart, Voxel ranks #69 out of 87 companies in the Medical Diagnostics & Research industry, placing it in the top 79.3%.
Is Voxel's Median PS Value too high?
Voxel's current Median PS Value of zł84.44 is 6497% above median its 10-year median of 1.28. Over the past 10 years, this metric has ranged from a low of 0.57 to a high of 1.94. Based on the distribution chart, Voxel ranks #69 out of 87 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Voxel has a GF Score™ of 97/100, reflecting its overall financial health beyond just this single metric.
How does Voxel's Median PS Value compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Voxel ranks #69 out of 87 companies for Median PS Value. This places Voxel in the lower half of its industry. The industry median Median PS Value is 0.88. Historically, Voxel's own Median PS Value has ranged from 0.57 to 1.94 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Diagnostics & Research company?
The median Median PS Value among Medical Diagnostics & Research companies is 0.88, based on 87 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Voxel and its competitors. For the Medical Diagnostics & Research industry, the median Median PS Value is 0.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Voxel's current Median PS Value is zł84.44, which is 6497% above median its own 10-year median of 1.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Voxel stock overvalued right now?
Voxel (LTS:0QDB) has a current Median PS Value of zł84.44. The stock's GF Value™ is zł128.03, compared to a current price of zł109.00 — trading 14.9% below its estimated fair value. The current Median PS Value is zł84.44, which is 6497% above median its 10-year median of 1.28. Voxel's overall GF Score™ is 97/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Voxel (LTS:0QDB), the current Median PS Value is zł84.44 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Voxel (LTS:0QDB) Overvalued in 2026?
Based on GuruFocus' analysis, Voxel stock appears to be undervalued.
The current stock price of zł109.00 is trading 14.9% below its estimated GF Value™ of zł128.03.
Key valuation signals for LTS:0QDB:
Median PS Value: zł84.44 (6497% above median its 10-year median of 1.28)
GF Value™: zł128.03 vs. price of zł109.00 (14.9% below fair value)
No single metric tells the full story. See the LTS:0QDB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Voxel SA is a network of diagnostic imaging laboratories created for patients and to increase access to high-quality tests. The company operates diagnostic imaging centers and laboratories and provides several services such as magnetic resonance imaging, computed tomography and positron emission tomography. It has 33 specialised laboratories in 21 cities throughout Poland.
97GF Score
Get the complete analysis for LTS:0QDB
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0QDB has been successfully added to your 
